1
|
Wang J, Xie L, Yang C, Ren C, Zhou K, Wang B, Zhang Z, Wang Y, Jin K, Yang GY. Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10. Front Cell Neurosci 2015; 9:361. [PMID: 26441532 PMCID: PMC4568339 DOI: 10.3389/fncel.2015.00361] [Citation(s) in RCA: 76] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2015] [Accepted: 08/28/2015] [Indexed: 11/23/2022] Open
Abstract
Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural stem/progenitor cell proliferation is unclear. We explored the effect of Tregs on neurogenesis in the subventricular zone (SVZ) after ischemia. Tregs were isolated and activated in vitro. Adult male C57BL/6 mice underwent 60 min transient middle cerebral artery occlusion (tMCAO). Then Tregs (1 × 105) were injected into the left lateral ventricle (LV) of normal and ischemic mouse brain. Neurogenesis was determined by immunostaining. The mechanism was examined by inhibiting interleukin 10 (IL-10) and transforming growth factor (TGF-β) signaling. We found that the number of BrdU+ cells in the SVZ was significantly increased in the activated Tregs-treated mice. Double immunostaining showed that these BrdU+ cells expressed Mash1. Blocking IL-10 reduced the number of Mash1+/BrdU+ cells, but increased the amount of GFAP+/BrdU+ cells. Here, we conclude that activated Tregs enhanced neural stem cell (NSC) proliferation in the SVZ of normal and ischemic mice; blockage of IL-10 abolished Tregs-mediated NSC proliferation in vivo and in vitro. Our results suggest that activated Tregs promoted NSC proliferation via IL-10, which provides a new therapeutic approach for ischemic stroke.
Collapse
Affiliation(s)
- Jixian Wang
- Department of Neurology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China ; Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University Shanghai, China ; Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Luokun Xie
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Chenqi Yang
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Changhong Ren
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Kaijing Zhou
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Brian Wang
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Zhijun Zhang
- Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University Shanghai, China
| | - Yongting Wang
- Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University Shanghai, China
| | - Kunlin Jin
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, TX, USA
| | - Guo-Yuan Yang
- Department of Neurology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China ; Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University Shanghai, China
| |
Collapse
|
2
|
Bucharles C, Bizet P, Arthaud S, Arabo A, Leprince J, Lefranc B, Cartier D, Anouar Y, Lihrmann I. Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle. J Comp Neurol 2014; 522:2634-49. [DOI: 10.1002/cne.23553] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2013] [Revised: 01/23/2014] [Accepted: 01/23/2014] [Indexed: 11/08/2022]
Affiliation(s)
- Christine Bucharles
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Patrice Bizet
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Sébastien Arthaud
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Arnaud Arabo
- Normandy University, University of Rouen; Mont-Saint-Aignan France
- Faculty of Sciences; University of Rouen; Mont-Saint-Aignan France
| | - Jérôme Leprince
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Benjamin Lefranc
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Dorthe Cartier
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Youssef Anouar
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| | - Isabelle Lihrmann
- Inserm, U982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine; University of Rouen; Mont-Saint-Aignan France
- Normandy University, University of Rouen; Mont-Saint-Aignan France
| |
Collapse
|